• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Comparing methods of measuring treatment intensification in hypertension care.比较高血压护理中测量治疗强化的方法。
Circ Cardiovasc Qual Outcomes. 2009 Jul;2(4):385-91. doi: 10.1161/CIRCOUTCOMES.108.838649. Epub 2009 Jun 16.
2
Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.动态血压与诊室血压用于评估临床试验中抗高血压疗效:来自Val-Syst研究的见解
Clin Ther. 2004 Sep;26(9):1436-45. doi: 10.1016/j.clinthera.2004.09.003.
3
A comparison between antihypertensive medication adherence and treatment intensification as potential clinical performance measures.作为潜在临床绩效指标的抗高血压药物依从性与治疗强化之间的比较。
Circ Cardiovasc Qual Outcomes. 2012 May;5(3):276-82. doi: 10.1161/CIRCOUTCOMES.112.965665. Epub 2012 May 10.
4
Understanding racial disparities in treatment intensification for hypertension management.了解高血压管理中强化治疗方面的种族差异。
J Gen Intern Med. 2010 Aug;25(8):819-25. doi: 10.1007/s11606-010-1342-9. Epub 2010 Apr 13.
5
Intensifying therapy for hypertension despite suboptimal adherence.尽管依从性欠佳仍强化高血压治疗。
Hypertension. 2009 Sep;54(3):524-9. doi: 10.1161/HYPERTENSIONAHA.109.133389. Epub 2009 Jul 6.
6
Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.强化治疗和药物治疗不依从对冠心病患者血压控制的重要性。
Arch Intern Med. 2008 Feb 11;168(3):271-6. doi: 10.1001/archinternmed.2007.72.
7
Hypertension treatment intensification among stroke survivors with uncontrolled blood pressure.血压未得到控制的中风幸存者的高血压治疗强化
Stroke. 2015 Feb;46(2):465-70. doi: 10.1161/STROKEAHA.114.007566. Epub 2014 Dec 30.
8
Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals.治疗惰性是实现《健康人民2010》血压控制目标的一个障碍。
Hypertension. 2006 Mar;47(3):345-51. doi: 10.1161/01.HYP.0000200702.76436.4b. Epub 2006 Jan 23.
9
Long-term Outcomes of the Effects of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Among Adults With Uncontrolled Hypertension: Follow-up of a Cluster Randomized Clinical Trial.家庭血压远程监测和药师管理对血压控制不佳的成年人血压影响的长期结果:一项集群随机临床试验的随访。
JAMA Netw Open. 2018 Sep 7;1(5):e181617. doi: 10.1001/jamanetworkopen.2018.1617.
10
Good knowledge about hypertension is linked to better control of hypertension; a multicentre cross sectional study in Karachi, Pakistan.对高血压的充分了解与更好地控制高血压相关;巴基斯坦卡拉奇的一项多中心横断面研究。
BMC Res Notes. 2012 Oct 24;5:579. doi: 10.1186/1756-0500-5-579.

引用本文的文献

1
Evidence for Age Bias Contributing to Therapeutic Inertia in Blood Pressure Management: A Secondary Analysis of SPRINT.证据表明年龄偏见导致降压治疗惰性:SPRINT 的二次分析。
Hypertension. 2023 Jul;80(7):1484-1493. doi: 10.1161/HYPERTENSIONAHA.123.21323. Epub 2023 May 11.
2
Randomized trial protocol for remote monitoring for equity in advancing the control of hypertension in safety net systems (REACH-SNS) study.随机试验方案:远程监测安全网系统中高血压控制进展公平性的研究(REACH-SNS)。
Contemp Clin Trials. 2023 Mar;126:107112. doi: 10.1016/j.cct.2023.107112. Epub 2023 Feb 3.
3
Tracking Blood Pressure Control Performance and Process Metrics in 25 US Health Systems: The PCORnet Blood Pressure Control Laboratory.追踪 25 个美国卫生系统中的血压控制表现和流程指标:PCORnet 血压控制实验室。
J Am Heart Assoc. 2021 Nov 2;10(21):e022224. doi: 10.1161/JAHA.121.022224. Epub 2021 Oct 6.
4
Treatment Intensification for Elevated Blood Pressure and Risk of Recurrent Stroke.强化血压治疗与复发性中风风险。
J Am Heart Assoc. 2021 Apr 6;10(7):e019457. doi: 10.1161/JAHA.120.019457. Epub 2021 Mar 31.
5
Using Values Affirmation to Reduce the Effects of Stereotype Threat on Hypertension Disparities: Protocol for the Multicenter Randomized Hypertension and Values (HYVALUE) Trial.利用价值观肯定来减少刻板印象威胁对高血压差异的影响:多中心随机高血压与价值观(HYVALUE)试验方案
JMIR Res Protoc. 2019 Mar 25;8(3):e12498. doi: 10.2196/12498.
6
Race-Specific Patterns of Treatment Intensification Among Hypertensive Patients Using Home Blood Pressure Monitoring: Analysis Using Defined Daily Doses in the Heart Healthy Lenoir Study.基于家庭血压监测的高血压患者强化治疗的种族特异性模式:以 Heart Healthy Lenoir 研究中的限定日剂量为分析指标。
Ann Pharmacother. 2019 Apr;53(4):333-340. doi: 10.1177/1060028018806001. Epub 2018 Oct 3.
7
Clinical inertia and the 2017 ACA/AHA guideline.临床惰性与2017年美国平价医疗法案/美国心脏协会指南
J Clin Hypertens (Greenwich). 2018 Oct;20(10):1392-1394. doi: 10.1111/jch.13373. Epub 2018 Sep 8.
8
Therapeutic Inertia and Treatment Intensification.治疗惰性与治疗强化。
Curr Hypertens Rep. 2018 Jan 29;20(1):4. doi: 10.1007/s11906-018-0802-1.
9
Associations of Four Community Factors With Longitudinal Change in Hemoglobin A Levels in Patients With Type 2 Diabetes.四种社区因素与 2 型糖尿病患者血红蛋白 A 水平纵向变化的关联。
Diabetes Care. 2018 Mar;41(3):461-468. doi: 10.2337/dc17-1200. Epub 2017 Dec 19.
10
Total antihypertensive therapeutic intensity score and its relationship to blood pressure reduction.总降压治疗强度评分及其与血压降低的关系。
J Am Soc Hypertens. 2016 Dec;10(12):906-916. doi: 10.1016/j.jash.2016.10.005. Epub 2016 Oct 28.

本文引用的文献

1
When more is not better: treatment intensification among hypertensive patients with poor medication adherence.何时并非越多越好:药物依从性差的高血压患者强化治疗情况
Circulation. 2008 Jun 3;117(22):2884-92. doi: 10.1161/CIRCULATIONAHA.107.724104. Epub 2008 May 27.
2
The role of clinical uncertainty in treatment decisions for diabetic patients with uncontrolled blood pressure.临床不确定性在血压控制不佳的糖尿病患者治疗决策中的作用。
Ann Intern Med. 2008 May 20;148(10):717-27. doi: 10.7326/0003-4819-148-10-200805200-00004.
3
Effect of unrelated comorbid conditions on hypertension management.无关共病状况对高血压管理的影响。
Ann Intern Med. 2008 Apr 15;148(8):578-86. doi: 10.7326/0003-4819-148-8-200804150-00002.
4
Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.糖尿病患者为何未达到推荐的风险因素目标?是依从性差还是缺乏强化治疗?
J Gen Intern Med. 2008 May;23(5):588-94. doi: 10.1007/s11606-008-0554-8. Epub 2008 Mar 4.
5
Importance of therapy intensification and medication nonadherence for blood pressure control in patients with coronary disease.强化治疗和药物治疗不依从对冠心病患者血压控制的重要性。
Arch Intern Med. 2008 Feb 11;168(3):271-6. doi: 10.1001/archinternmed.2007.72.
6
Failure to intensify antihypertensive treatment by primary care providers: a cohort study in adults with diabetes mellitus and hypertension.初级保健提供者未能强化抗高血压治疗:一项针对糖尿病和高血压成人患者的队列研究。
J Gen Intern Med. 2008 May;23(5):543-50. doi: 10.1007/s11606-008-0507-2. Epub 2008 Jan 25.
7
Understanding uncontrolled hypertension: is it the patient or the provider?理解未控制的高血压:问题出在患者还是医疗服务提供者身上?
J Clin Hypertens (Greenwich). 2007 Dec;9(12):937-43. doi: 10.1111/j.1524-6175.2007.07332.x.
8
The accuracy of clinician perceptions of "usual" blood pressure control.临床医生对“常规”血压控制的认知准确性。
J Gen Intern Med. 2008 Feb;23(2):180-3. doi: 10.1007/s11606-007-0464-1. Epub 2007 Nov 28.
9
Reasons for not intensifying medications: differentiating "clinical inertia" from appropriate care.不强化药物治疗的原因:区分“临床惰性”与适当治疗。
J Gen Intern Med. 2007 Dec;22(12):1648-55. doi: 10.1007/s11606-007-0433-8. Epub 2007 Oct 24.
10
Competing demands or clinical inertia: the case of elevated glycosylated hemoglobin.相互冲突的需求或临床惰性:糖化血红蛋白升高的案例
Ann Fam Med. 2007 May-Jun;5(3):196-201. doi: 10.1370/afm.679.

比较高血压护理中测量治疗强化的方法。

Comparing methods of measuring treatment intensification in hypertension care.

作者信息

Rose Adam J, Berlowitz Dan R, Manze Meredith, Orner Michelle B, Kressin Nancy R

机构信息

Center for Health Quality, Outcomes, and Economic Research, Bedford VA Medical Center, Bedford, MA 01730, USA.

出版信息

Circ Cardiovasc Qual Outcomes. 2009 Jul;2(4):385-91. doi: 10.1161/CIRCOUTCOMES.108.838649. Epub 2009 Jun 16.

DOI:10.1161/CIRCOUTCOMES.108.838649
PMID:20031865
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2801893/
Abstract

BACKGROUND

Greater treatment intensification (TI) improves hypertension control. However, we do not know the ideal way to measure TI for research and quality improvement efforts. We compared the ability of different TI measures to predict blood pressure (BP) control.

METHODS AND RESULTS

We enrolled 819 hypertensive outpatients from an urban academic hospital. Each patient was assigned 3 scores to characterize TI. The any/none score divides patients into those who had any therapy increases during the study versus none. The norm-based method models the chance of a medication increase at each visit, then scores each patient based on whether they received more or fewer medication increases than predicted. The standard-based method is similar to the norm-based method but expects a medication increase whenever the blood pressure is uncontrolled. We compared the ability of these scores to predict the final systolic blood pressure (SBP). The any/none score showed a paradoxical result: any therapy increase was associated with SBP 4.6 mm Hg higher than no increase (P<0.001). The norm-based method score did not predict SBP in a linear fashion (P=0.18); further investigation revealed a U-shaped relationship between the norm-based method score and SBP. However, the standard-based method score was a strong linear predictor of SBP (2.1 mm Hg lower for each additional therapy increase per 10 visits, P<0.001). Similarly, the standard-based method predicted dichotomized blood pressure control, as measured by SBP <140 mm Hg (odds ratio, 1.30; P<0.001).

CONCLUSIONS

Our results suggest that standard-based method is the preferred measure of treatment intensity for hypertension care.

摘要

背景

更大程度的治疗强化(TI)可改善高血压控制情况。然而,我们尚不清楚用于研究和质量改进工作的TI理想测量方法。我们比较了不同TI测量方法预测血压(BP)控制的能力。

方法与结果

我们纳入了一家城市学术医院的819名高血压门诊患者。为每位患者分配3个分数以表征TI。“有/无”分数将患者分为在研究期间有任何治疗增加的患者与没有治疗增加的患者。基于规范的方法对每次就诊时药物增加的可能性进行建模,然后根据每位患者接受的药物增加次数高于或低于预测次数为其打分。基于标准的方法与基于规范的方法类似,但只要血压未得到控制就预期会增加药物。我们比较了这些分数预测最终收缩压(SBP)的能力。“有/无”分数显示出矛盾的结果:任何治疗增加都与SBP比未增加时高4.6 mmHg相关(P<0.001)。基于规范的方法分数并非以线性方式预测SBP(P=0.18);进一步研究揭示了基于规范的方法分数与SBP之间呈U形关系。然而,基于标准的方法分数是SBP的强线性预测指标(每10次就诊每增加一次额外治疗,SBP降低2.1 mmHg,P<0.001)。同样,基于标准的方法预测了以SBP<140 mmHg衡量的二分法血压控制情况(优势比,1.30;P<0.001)。

结论

我们的结果表明,基于标准的方法是高血压治疗强度的首选测量方法。